| In vitro: |
| J.Photoch.Photobiol. B , 1998, 45(2-3):87-94. | | Photocytotoxic effect of pseudohypericin versus hypericin.[Reference: WebLink] | Pseudohypericin and hypericin, the major photosensitizing constituents of Hypericum perforatum, are believed to cause hypericism.
METHODS AND RESULTS:
Since hypericin has been proposed as a photosensitizer for photodynamic cancer therapy, the photocytotoxicity of its congener Pseudohypericin has been investigated. The presence of foetal calf serum (FCS) or albumin extensively inhibits the photocytotoxic effect of Pseudohypericin against A431 tumour cells, and is associated with a large decrease in cellular uptake of the compound. These results suggest that Pseudohypericin, in contrast to hypericin, interacts strongly with constituents of FCS, lowering its interaction with cells.
CONCLUSIONS:
Since Pseudohypericin is two to three times more abundant in Hypericum than hypericin and the bioavailabilities of Pseudohypericin and hypericin after oral administration are similar, these results suggest that hypericin, and not Pseudohypericin, is likely to be the constituent responsible for hypericism. Moreover, the dramatic decrease of photosensitizing activity of Pseudohypericin in the presence of serum may restrict its applicability in clinical situations. | | P. Natl. Acad. Sci., 1989, 86(15):5963-7. | | Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin.[Reference: WebLink] |
METHODS AND RESULTS:
Administration of the aromatic polycyclic dione compounds hypericin or Pseudohypericin to experimental animals provides protection from disease induced by retroviruses that give rise to acute, as well as slowly progressive, diseases. For example, survival from Friend virus-induced leukemia is significantly prolonged by both compounds, with hypericin showing the greater potency. Viremia induced by LP-BM5 murine immunodeficiency virus is markedly suppressed after infrequent dosage of either substance. These compounds affect the retroviral infection and replication cycle at least at two different points: (i) Assembly or processing of intact virions from infected cells was shown to be affected by hypericin. Electron microscopy of hypericin-treated, virus-producing cells revealed the production of particles containing immature or abnormally assembled cores, suggesting the compounds may interfere with processing of gag-encoded precursor polyproteins. The released virions contain no detectable activity of reverse transcriptase. (ii) Hypericin and Pseudohypericin also directly inactivate mature and properly assembled retroviruses as determined by assays for reverse transcriptase and infectivity.
CONCLUSIONS:
Accumulating data from our laboratories suggest that these compounds inhibit retroviruses by unconventional mechanisms and that the potential therapeutic value of hypericin and Pseudohypericin should be explored in diseases such as AIDS. | | Cancer Prev. Res., 2010, 3(12 Supplement). | | Download citationShare Request full-text Pseudohypericin in Hypericum perforatum inhibited LPS-stimulated PGE2 and NO in mouse macrophages by potentiating SOCS3 expression[Reference: WebLink] | Hypericum perforatum, also known as ‘St John’s wort’, is one of the most studied medicinal plants. Despite its primary use as an anti-depression agent, certain compounds such as hypericin and hyperforin in H. perforatum extract have been shown to inhibit tumor growth by inducing apoptosis/necrosis and inhibiting angiogenesis. Using hypericin in photodynamic cancer therapy is also being studied. Our previous studies have demonstrated that H. perforatum extract and a group of 4 compounds in it, namely Pseudohypericin, amentoflavone, quercetin, and chlorogenic acid, decreased lipopolysaccharide (LPS)-stimulated macrophage inflammatory response, and identified the activation of suppressor of cytokine signaling 3 (SOCS3) as a candidate mechanism for this activity. Given that both inflammation and SOCS3 suppression are associated with tumor progression, we studied the role of SOCS3 activation in the anti-inflammatory activity of H. perforatum extract and its components.
METHODS AND RESULTS:
Specific siRNA was used to knockdown the expression of SOCS3 in RAW 264.7 mouse macrophages. Activation of SOCS3 in macrophages was measured at mRNA and protein levels using qRT-PCR and Western blot. H. perforatum extract at 30 μg/mL, the 4 compounds at the same concentrations as in the extract, and the combinations of individual compounds were applied to macrophages with and without SOCS3 knockdown to reveal whether their inhibition of LPS-stimulated prostaglandin E2 (PGE2) and nitric oxide (NO) was dependent on SOCS3. SOCS3 expression in the mouse macrophages was activated upon LPS stimulation and further potentiated by H. perforatum extract and the 4 compounds studied. SOCS3 siRNA transfection significantly compromised the activation of SOCS3. H. perforatum extract and the 4 compounds reduced LPS-stimulated PGE2 and NO production, but only the inhibitory effect of the 4 compounds was negated by SOCS3 knockdown. Combinations of two or three of the 4 compounds that include Pseudohypericin, the most essential component among the four that act synergistically in reducing macrophage inflammatory response, lost their inhibitory effect on PGE2 and NO production in SOCS3 knockdown cells.
CONCLUSIONS:
SOCS3 activation was critical for Pseudohypericin’s independent and interactive anti-inflammatory activity with amentoflavone, quercetin, and chlorogenic acid. H. perforatum extract utilized alternative mechanisms that are SOCS3 independent to inhibit macrophage inflammation. In addition to light-activated cytotoxicity and inhibition of angiogenesis, magnification of SOCS3 activation by H. perforatum extract might contribute to its anti-tumor potential. |
|
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)